You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Claims for Patent: 7,208,160

✉ Email this page to a colleague

Summary for Patent: 7,208,160

Title:	Process of treating sea algae and halophytic plants
Abstract:	The process of treating sea algae/halophytes. The sea algae/halophyte in an aqueous solution containing an acid is soaked for a sufficient length of time to substantially reduce the mineral content of the sea algae/halophyte. The initial mineral content is expressed on the basis of the total ash content of the untreated sea algae/halophyte in the dried state. The soak-treated sea algae is separated from the aqueous solution. The separated sea algae/halophyte can be dried to provide a dried sea algae/halophyte product having substantially reduced mineral content and increased nutritional value.
Inventor(s):	Sol Katzen
Assignee:	Katzen Avigail
Application Number:	US10/647,305

Details for Patent 7,208,160

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Sanofi Pasteur Limited	TENIVAC	tetanus and diphtheria toxoids adsorbed	Injection	103171	November 03, 2003	7,208,160	2023-08-26
Bristol-myers Squibb Company	YERVOY	ipilimumab	Injection	125377	March 25, 2011	7,208,160	2023-08-26
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.